Keywords: airway inflammation, asthma, glucagon-like peptide-1 (GLP-1), interleukin-33 (IL-33), type 2 inflammation Introduction As one of the most prevalent chronic illnesses, asthma continues to have a significant global burden of disease, affecting over 25 million people in the US and as many as 330 million people worldwide [1]
BPC-157 is not approved by the FDA or veterinary regulatory agencies for use in animals
Retatrutide is currently in Phase 3 clinical trials and is not yet FDA-approved
Mild side effects, such as stomach discomfort and nausea, may happen to some people
Larson, M
Ive set up and run a weight loss surgery service, doing gastric bands, sleeve gastrectomies and gastric bypasses